SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
2020 SESSION
HB 910 Pharmacy; compounding of drugs, regulation by Board of Pharmacy.
Introduced by: Marcus B. Simon | all patrons ... notes | add to my profiles
SUMMARY AS INTRODUCED:
Practice of pharmacy; compounding; regulation by Board of Pharmacy. Provides that the compounding of drugs provided to the Department of Corrections for the purpose of carrying out an execution by lethal injection constitutes the practice of pharmacy and is subject to the requirements of the Drug Control Act and the jurisdiction of the Board of Pharmacy. The bill provides that only outsourcing facilities may compound such drugs; currently, both pharmacies and outsourcing facilities may compound such drugs. The bill also clarifies that the Board of Pharmacy may inspect any pharmacy or other place where drugs, cosmetics, or devices are manufactured, stored, or dispensed in response to complaints received by the Board, in any case in which the Board has reason to believe that the pharmacy or such other place has violated any state or federal law, or as otherwise deemed necessary by the Board to protect the health and safety of the public. The bill replaces one of the two consumer positions on the Board of Health with a pharmacist with experience in compounding, requires the Board of Health to educate the public about safe use of compounded drugs, and requires the Board of Health and the Board of Pharmacy to report annually to the Governor and the General Assembly on actions taken (i) to ensure the safety and quality of compounded drugs produced by compounding pharmacies and outsourcing facilities located in the Commonwealth, as well as those outside the Commonwealth that provide compounded drugs to patients in the Commonwealth; (ii) to reduce illegal use of opioids and opioid abuse in the Commonwealth; and (iii) to implement provisions of and ensure compliance with the requirements of federal law related to prescription drug identification, tracing, and verification.
FULL TEXT
AMENDMENTS
HISTORY
- 01/07/20 House: Prefiled and ordered printed; offered 01/08/20 20101294D
- 01/07/20 House: Referred to Committee on Health, Welfare and Institutions
- 01/15/20 House: Assigned HWI sub: Health Professions
- 01/29/20 House: Subcommittee recommends laying on the table (4-Y 2-N)
- 02/11/20 House: Left in Health, Welfare and Institutions